Table 2.
Characteristics of studies included in the mortality analysis cohort
| Study | Country & City | Sample Size | Survivors | Non-survivors | ||||||
| n (%) | Age (yrs) | Women (%) | AKI (%) | n (%) | Age (yrs) | Women (%) | AKI (%) | |||
| Zhou F et al., [10] | Wuhan, China | 191 | 137 (71.7%) | 52 (45-58) | 56 (41%) | 36 (26.3%) | 54 (28.3%) | 69 (63-76) | 16 (30%) | 41 (75.9%) |
| Chen T et al., [12] | Wuhan, Chins | 274 | 161 (58.8%) | 51 (37-66) | 73 (45%) | 8 (5%) | 113 (41.2%) | 68 (62-77) | 30 (27%) | 44 (40%) |
| Yao et al., [25] | Dabieshan, China | 108 | 12 (11.1%) | - | - | 5 (41.7%) | 96 (88.9%) | 65.0 (51.0,73.5) |
5 (41%) | 18 (18.75%) |
| Wang Y et al., [30] | Wuhan, China | 344 | 211 (61.3%) | 57 (47-69) | 106 (50.2%) | 6 (2.8%) | 133 ((38.7%) | 70 (62-77) | 59 (44.4%) | 80 (60.2%) |
| Yang et al., [11] | Wuhan, China | 52 | 20 (38.5%) | 51.9±12.9 | 6 (30%) | 3 (15%) | 32 (61.5%) | 64.6±11.2 | 11 (34%) | 12 (37.5%) |
| Deng et al., [31] | Wuhan, China | 225 | 116 (51.6%) | 40 (33-57) | 65 (56%) | 0 (0%) | 109 (48.4%) | 69 (62-74) | 36 (33%) | 20 (18.3%) |
| Ruan et al., [32] | Wuhan, China | 150 | 82 (54.7%) | 50 (44-81) | 29 (35%) | 2 (2.4%) | 68 (45.3%) | 67 (15-81) | 19 (28%) | 21 (30.9%) |
| Richardson et al., [33] | New York, USA | 2358 | 1869 (79.3%) | - | - | 176 (9.4%) | 489 (20.7%) | - | - | 347 (70.9%) |